https://www.selleckchem.com/mTOR.html
e and the most common was lymphopenia (14%) with no incidence of myelodysplasia/leukemia. Conclusion In patients with advanced progressive lung NET and satisfactory SSR expression, 177Lu-DOTATATE is effective and safe with a high disease control rate and encouraging PFS and OS.Most breast cancers express androgen receptors (AR). This prospective imaging sub-study explored imaging AR with 18F-fluoro-5α-dihydrotestosterone (FDHT)-PET in patients with metastatic breast cancer (MBC) receiving selective AR modulation (SARM) therapy (GTx-024, GTx, Inc).
Aimer
Commentaire
Partagez
